Summary of share price highs, lows and changes for 3M
Historical stock prices
Current Share Price	US$169.59
52 Week High	US$177.41
52 Week Low	US$139.34
Beta	1.08
1 Month Change	4.79%
3 Month Change	16.17%
1 Year Change	13.59%
3 Year Change	52.52%
5 Year Change	-14.42%
Change since IPO	2,794.34%

Recent News & Updates

Seeking Alpha • Jul 21

3M: The Turnaround Is Real, But Already Priced In

Summary 3M Company remains a Hold as valuation reached its fair value, even when taking into account the strong Q2 performance and guidance boost. 3M delivered 5.4% sales growth, 12% EPS growth in H1, and raised 2026 EPS guidance to $8.80–$8.95. Litigation liabilities and macro/geopolitical risks continue to weigh on 3M's risk-reward profile. AI/data center exposure and portfolio optimization offer long-term growth, but current risk-reward is unattractive. Read the full article on Seeking Alpha

Narrative Update • Jul 20

MMM: PFAS Lawsuits Will Continue To Cap Upside Despite Improving Demand

Analysts have adjusted their fair value estimate for 3M slightly lower to about $121.62. This reflects a modestly higher discount rate alongside marginally stronger assumptions for revenue growth, profit margins, and a lower future P/E, informed by recent price target changes that highlight both optimism around improving industrial demand and ongoing concerns about execution and legacy risks.

Recent updates

Seeking Alpha • Jul 21

3M: The Turnaround Is Real, But Already Priced In

Narrative Update • Jul 20

MMM: PFAS Lawsuits Will Continue To Cap Upside Despite Improving Demand

Narrative Update • Jul 06

MMM: Transformation And Legal Progress Will Support Future Re Rating

Analysts have trimmed their fair value estimate for 3M from $222.65 to $209.00. This reflects updated assumptions around discount rates, profit margins, and longer running concerns such as persistent PFAS liabilities and questions about the pace of the company's innovation recovery.

Narrative Update • Jun 22

MMM: Future Margin Execution Faces PFAS Legal Risks After Solventum Spin

Analysts have trimmed their price expectations for 3M, with the updated fair value estimate moving from about $175.03 to $170.97, as recent research has highlighted concerns around execution risks in reigniting growth and ongoing PFAS liabilities, even as margin assumptions improved slightly. Analyst Commentary Recent Street research on 3M points to a mixed setup, with analysts split between concerns around execution and liabilities and some recognition that management has pulled meaningful levers through the ongoing transformation and portfolio moves such as the Solventum spin.

Narrative Update • Jun 06

MMM: PFAS Lawsuit And Overhang Will Constrain Future Upside Potential

Analysts have adjusted their view on 3M, with the implied fair value price target moving from about $125.70 to around $127.90. This reflects updated assumptions on revenue growth, profit margins, and future P/E following the Solventum spin and mixed recent price target changes across the Street.

Narrative Update • May 23

MMM: Margin Execution And Cash Returns Will Support Future Re Rating

Analysts have trimmed their 3M price target by about $1, reflecting slightly lower fair value estimates even as updated models factor in a reduced discount rate, modestly higher revenue growth, a small uptick in projected profit margins, and a somewhat lower future P/E assumption. Analyst Commentary Recent Street research around 3M and its healthcare spin-off Solventum gives you a mixed but generally constructive picture, with attention on how the separation could reshape both companies' earnings profiles and valuation frameworks.

Narrative Update • May 03

MMM: Future Margin Execution And Buybacks Will Support Turnaround Prospects

Analysts have adjusted the 3M price target slightly lower to reflect a new fair value near $175, as recent target cuts from several firms and one smaller increase from Wells Fargo suggest a more cautious view on profit margins, while revenue growth assumptions and future P/E expectations remain steady to slightly higher. Analyst Commentary Recent Street research reflects a more mixed stance on 3M, with several firms trimming price targets and one lifting its target, all clustering around a fair value in the mid US$170s.

Narrative Update • Apr 18

MMM: Execution On Margin Efficiency And Buybacks Will Support Future Re Rating

Analysts have trimmed their 3M fair value estimate by about $2 to $223.59, reflecting slightly lower profit margin assumptions that are only partly balanced by a modestly higher revenue growth outlook and a marginally richer future P/E multiple. Analyst Commentary Recent Street research on 3M reflects a mix of cautious revisions and selective optimism, with several firms adjusting price targets both higher and lower in response to updated assumptions.

Narrative Update • Apr 04

MMM: Operational Discipline And Legal Resolution Will Support Future Re Rating

Analysts have reduced the updated price target on 3M by about $1 to $225.94. This reflects a combination of recent target cuts and increases across firms, along with slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E.

Narrative Update • Mar 21

MMM: Operational Progress And Legal Overhang Resolution Will Support Future Re Rating

The analyst price target for 3M has been adjusted by a few dollars, reflecting mixed but generally constructive updates from recent research. Some firms raised their targets by $2 to $5, while others trimmed theirs by $6 to $8, based on refreshed views of growth, profitability, and valuation assumptions.

Narrative Update • Mar 06

MMM: Digital And Legal Progress Will Support Future Re Rating

The analyst price target for 3M has edged higher by about $1.50, as analysts weighed mixed target moves from major firms alongside slightly updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent Street research on 3M has been mixed, with some firms trimming their price targets while others raised theirs.

Narrative Update • Feb 20

MMM: Digital Execution And Slightly Higher Fair Value Will Support Re Rating

The analyst price target for 3M has shifted slightly higher, with our fair value estimate moving from $223.00 to about $225.67 as analysts factor in updated growth and margin assumptions, along with mixed target revisions across major firms. Analyst Commentary Recent Street research on 3M shows a split view, with several bullish analysts lifting price targets and others trimming expectations or downgrading the stock.

Narrative Update • Feb 05

MMM: Turnaround Prospects Will Be Tested By PFAS Litigation And Mixed Street Expectations

The analyst price target on 3M has been revised slightly higher to about $177 from $174, as analysts adjust their models for small changes in fair value, discount rate, revenue growth, profit margin, and future P/E assumptions following a mix of recent target increases and cuts across major firms. Analyst Commentary Recent Street research on 3M has been mixed, with several firms adjusting their price targets in both directions and one major downgrade.

Narrative Update • Jan 22

MMM: New Digital Tools And Higher P E Multiple Will Support Re Rating

Analysts have nudged their valuation view on 3M higher, with the updated fair value estimate moving from $212 to $223 as they reassess the stock's longer term earnings power and apply a slightly richer future P/E multiple, despite mixed recent price target changes across the Street. Analyst Commentary Recent Street research on 3M has been mixed, with some firms trimming targets or ratings and others lifting their valuation marks.

Narrative Update • Jan 07

MMM: Reset Expectations And New Products Will Support Higher Margins

Analysts have raised their fair value estimate for 3M to $212 from $187, citing expectations for higher profit margins, a slightly lower discount rate, and supportive Street research that highlights Q3 execution, new product traction, and reset expectations across multiple firms. Analyst Commentary Recent Street research around 3M clusters around a more constructive setup following Q3, with several bullish analysts revisiting their models on the back of reset expectations, new product traction, and updated legal and macro assumptions.

Narrative Update • Dec 24

MMM: PFAS Litigation Will Ultimately Cap Upside Despite Turnaround Progress

Analysts have raised their price target on 3M, lifting fair value by about $12 per share to roughly $126 as they grow more confident in the company’s improving organic growth, margin expansion, and turnaround initiatives, despite ongoing PFAS litigation risks. Analyst Commentary Recent Street research reflects a more balanced, but still risk aware, view on 3M as estimates reset and execution on the turnaround improves.

Narrative Update • Dec 10

MMM: Turnaround Progress Will Face Ongoing PFAS Litigation And Portfolio Reshaping Risks

Our fair value estimate for 3M has been trimmed slightly to $174.25 from $174.94 as analysts balance higher price targets and improving expectations for new product driven growth and management's turnaround progress against persistent PFAS litigation risk. Analyst Commentary Street research remains divided on 3M, with recent notes highlighting improving execution and product driven growth, offset by continued concern around PFAS liabilities and mixed end market demand.

Narrative Update • Nov 26

MMM: Shares Will Balance Turnaround Progress With Litigation and Asset Sale Uncertainty

Analysts have marginally raised their fair value estimate for 3M to $174.94, citing improved organic growth, ongoing new product introductions, and increased profit margin expectations following recent quarterly results. Analyst Commentary Recent analyst research has revealed a shifting perspective on 3M, as several experts adjust their outlooks based on the company’s latest earnings performance and ongoing strategic initiatives.

Narrative Update • Nov 06

MMM: Shares Will Balance Turnaround Progress With Ongoing Litigation and Portfolio Changes

Analysts have raised their fair value estimate for 3M to $174.31 from $167.81. This change reflects improved organic growth prospects and progress on turnaround initiatives highlighted in recent research updates.

Narrative Update • Oct 22

Analysts Divided on 3M as Fair Value Rises Amid New Initiatives and Persistent Risks

3M's fair value estimate has increased by $5.00 to $167.81 as analysts cite modest operating outperformance and positive momentum from new product initiatives, despite some lingering concerns. Analyst Commentary Recent updates from Street research highlight diverging analyst sentiment regarding 3M's valuation trajectory and execution on strategic initiatives.

Narrative Update • Oct 08

New Product Launches And Efficiency Gains Will Boost Future Value

Narrative Update: 3M Analyst Price Target Revision Analysts have increased their price target for 3M to $162.81 from $161.63, citing improved full-year guidance prospects and renewed interest as a short-term buy idea. Analyst Commentary Recent commentary from Street research highlights both optimistic and cautious stances regarding 3M’s near-term prospects.

Seeking Alpha • Mar 11

3M: Multiple Expansion Amidst Turnaround Success

Summary 3M has shown signs of a turnaround with a doubling stock price since October 2023, but operational top line growth remains modest, justifying a "hold" rating. The company expects modest organic revenue growth of 2-3% in 2025, driven by innovations and new product launches, but analysts are less optimistic. Current valuation is high with a forward P/E ratio above the five-year median, limiting upside potential amid risks like trade disputes and economic slowdowns. Read the full article on Seeking Alpha

Seeking Alpha • Feb 07

3M: More Upside Ahead - But Wait For A Moderate Retracement

Summary MMM's reversal is already here, thanks to the SOLV divestiture bringing forth a more focused portfolio and healthier balance sheet. This is on top of the resolution of its legal headwinds, as management also pursues insurance recovery and $340M already completed. The management has driven new growth opportunities through its legacy businesses and new product launches as well, despite certain market softness. These reasons are likely why the market has upgraded MMM's valuations and the investors have defended the stock's uptrend support line thus far. With double digit capital appreciation prospects, we are reiterating our Buy rating here with one caveat. We shall further discuss. Read the full article on Seeking Alpha

Seeking Alpha • Jan 23

3M Is Structurally Shifting For Durable Growth

Summary 3M's focus on innovation and operational improvements under CEO Bill Brown may lead to significant top-line growth and margin expansion. Management is aiming to enhance supply chain efficiencies and increasing production launches while improving the firm's on-time, in-full deliveries. 3M has a substantial amount of inventory that may be worked down in the coming quarters, potentially acting as a tailwind for free cash flow generation in the coming years. Read the full article on Seeking Alpha

Seeking Alpha • Jan 06

Downgrading 3M Due To Persistent Litigation Risks And Stagnant Sales Growth

Summary I am downgrading 3M from hold to sell due to slow revenue growth, ongoing litigation risks, and inflated stock valuation despite recent gains. Revenue growth is expected to underpace inflation, driven by product line adjustments, declining European demand, and the healthcare spin-off. Despite settling some litigations, 3M faces significant pending lawsuits, posing substantial financial risks. Shares appear expensive when accounting for slow growth and litigation risks, with a fair value estimate of $86 per share, 34% below current trading. Read the full article on Seeking Alpha

Seeking Alpha • Dec 30

One Of JPMorgan's Value Picks For 2025, 3M Could Have A Bright Year Ahead

Summary JPMorgan highlights 3M Company as a key investment idea for 2025, despite ongoing legal challenges and growth issues, leading to my Hold rating. 3M's diverse operations span Safety & Industrial, Transportation & Electronics, Consumer, and Healthcare, with a strong focus on innovation and high-margin products. The company reported 1% organic growth and an 18% rise in adjusted EPS for Q3 2024, showcasing operational efficiency and cost management. With a healthy 23% margin and $1.5 billion free cash flow, MMM balances rewarding shareholders with investing in growth initiatives. Read the full article on Seeking Alpha

Seeking Alpha • Nov 25

3M: Seems A Bit Too Expensive Considering The Slow Growth

Summary Earlier this year, CEO William Brown said 3M's products are aging. Now and in the near future, it seems like the company is focussing on new products and research. It seems like the uncertainty-creating lawsuits are now largely settled, but the costs will weigh on the company for several years to come. Nevertheless, 3M has a strong financial position and rewards its shareholders with dividends and buybacks, but I'm waiting because I believe it is slightly too expensive. Read the full article on Seeking Alpha

Seeking Alpha • Oct 24

3M: Multiple Expansion But Problems Linger

Summary 3M's Q3 earnings beat expectations with $1.98/share, driven by margin expansion from restructuring, despite lackluster 1.5% organic revenue growth. The company repurchased $700 million in stock, raising concerns about prioritizing buybacks over addressing future PFAS liabilities and debt reduction. 3M faces significant PFAS-related lawsuits, posing potential billions in liabilities, making stock buybacks questionable given the financial risks. Despite a 30% stock appreciation, driven by multiple expansion, revenue growth remains below inflation, and future liabilities pose significant downside risks. Read the full article on Seeking Alpha

Shareholder Returns

	MMM	US Industrials	US Market
7D	4.8%	5.5%	-1.4%
1Y	13.6%	-29.1%	16.4%

Return vs Industry: MMM exceeded the US Industrials industry which returned -29.1% over the past year.

Return vs Market: MMM underperformed the US Market which returned 16.4% over the past year.

Price Volatility

Is MMM's price volatile compared to industry and market?
MMM volatility
MMM Average Weekly Movement	3.7%
Industrials Industry Average Movement	14.1%
Market Average Movement	7.1%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.2%

Stable Share Price: MMM has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: MMM's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1902	60,500	Bill Brown	www.3m.com

3M Company provides diversified technology services in the America, the Asia Pacific, Europe, the Middle East, Africa, and internationally. It operates through three segments: Safety and Industrial, Transportation and Electronics, and Consumer. The Safety and Industrial segment provides industrial abrasives and finishing for metalworking applications; autobody repair solutions; industrial specialty products, such as personal hygiene products, masking, and packaging materials; electrical products and materials for construction and maintenance, power distribution, and electrical original equipment manufacturers; structural adhesives and tapes; respiratory, hearing, eye, and fall protection solutions; and natural and color-coated mineral granules for shingles.

3M Company Fundamentals Summary

How do 3M's earnings and revenue compare to its market cap?
MMM fundamental statistics
Market cap	US$88.06b
Earnings (TTM)	US$3.00b
Revenue (TTM)	US$25.18b

29.2x

P/E Ratio

3.5x

P/S Ratio

Is MMM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MMM income statement (TTM)
Revenue	US$25.18b
Cost of Revenue	US$15.26b
Gross Profit	US$9.92b
Other Expenses	US$6.93b
Earnings	US$3.00b

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	5.81
Gross Margin	39.41%
Net Profit Margin	11.90%
Debt/Equity Ratio	417.7%

How did MMM perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

53%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/23 22:02
End of Day Share Price	2026/07/23 00:00
Earnings	2026/06/30
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

3M Company is covered by 29 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
John Eade	Argus Research Company
Julian Mitchell	Barclays
Robert Cornell	Barclays

3M (MMM) Stock Overview

Rewards

Risk Analysis

Analyst Price Targets

Analysts Divided on 3M as Fair Value Rises Amid New Initiatives and Persistent Risks

PFAS Risks And Supply Chain Issues Will Test Margins

Digitalization And IoT Adoption Will Drive Smart Infrastructure Growth

Top Analyst Narratives

Analysts Divided on 3M as Fair Value Rises Amid New Initiatives and Persistent Risks

PFAS Risks And Supply Chain Issues Will Test Margins

Digitalization And IoT Adoption Will Drive Smart Infrastructure Growth

3M Company Competitors

Honeywell International

Illinois Tool Works

Johnson Controls International

PACCAR

Price History & Performance

Recent News & Updates

Executive VP notifies of intention to sell stock

Second quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behind

3M: The Turnaround Is Real, But Already Priced In

MMM: PFAS Lawsuits Will Continue To Cap Upside Despite Improving Demand

3M Partners With Microsoft Azure to Deploy Expanded Beam Optical in Data Centers

Scotch Brand Launches Scotch Kids Tape For Young Creators

Recent updates

Executive VP notifies of intention to sell stock

Second quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behind

3M: The Turnaround Is Real, But Already Priced In

MMM: PFAS Lawsuits Will Continue To Cap Upside Despite Improving Demand

3M Partners With Microsoft Azure to Deploy Expanded Beam Optical in Data Centers

Scotch Brand Launches Scotch Kids Tape For Young Creators

New York Sues 3M Over Alleged Decades of PFAS Chemical Contamination

3M Company to Report Q2, 2026 Results on Jul 21, 2026

MMM: Transformation And Legal Progress Will Support Future Re Rating

3M Named Official Material Science Partner for Cadillac Formula 1 Team

Now 21% undervalued

3M Wins Long-Term Airbus Deal for Advanced A220 Aircraft Insulation Materials

MMM: Future Margin Execution Faces PFAS Legal Risks After Solventum Spin

3M Stock Gains on Q2 Revenue Strength and Margin Progress After Litigation Settlements

3M Company Announces Election of Jennifer W. Rumsey to the Board of Directors and member of the Science, Technology and Sustainability Committee of the Board, Effective June 5, 2026

MMM: PFAS Lawsuit And Overhang Will Constrain Future Upside Potential

MMM: Margin Execution And Cash Returns Will Support Future Re Rating

First quarter dividend of US$0.78 announced

3M Company Declares Quarterly Dividend for the Second Quarter of 2026, Payable on June 12, 2026

Executive VP exercised options to buy US$1.1m worth of stock.

MMM: Future Margin Execution And Buybacks Will Support Turnaround Prospects

3M Faces A$1.4b Australian Lawsuit Over PFAS as Shares Trade Lower

First quarter 2026 earnings: EPS misses analyst expectations

MMM: Execution On Margin Efficiency And Buybacks Will Support Future Re Rating

Insider exercised options to buy US$80k worth of stock.

MMM: Operational Discipline And Legal Resolution Will Support Future Re Rating

3M Company, Annual General Meeting, May 12, 2026

MMM: Operational Progress And Legal Overhang Resolution Will Support Future Re Rating

MMM: Digital And Legal Progress Will Support Future Re Rating

3M Company Introduces Brite by Scotch-Brite Collection of Kitchen Cleaning Tools

MMM: Digital Execution And Slightly Higher Fair Value Will Support Re Rating

3M Company Appoints Meagan Linn as Senior Vice President, Government Affairs

Insider recently sold US$310k worth of stock

Insider notifies of intention to sell stock

Fourth quarter dividend increased to US$0.78

MMM: Turnaround Prospects Will Be Tested By PFAS Litigation And Mixed Street Expectations

3M Company Appoints Neil G. Mitchill to Board of Directors and Member of the Audit Committee and the Nominating and Governance Committee of the Board, Effective Feb. 6, 2026

3M Company Declares Quarterly Dividend, Payable on March 12, 2026

MMM: New Digital Tools And Higher P E Multiple Will Support Re Rating

Now 20% undervalued after recent price drop

MMM: Reset Expectations And New Products Will Support Higher Margins

Montana Court Denies Motions to Dismiss Class-Action Lawsuit Fighting PFAS in Firefighter Turnout Gear

3M to Debut AI-Powered Assistant 'Ask 3M' and Expanded 3M Digital Materials Hub At CES 2026

MMM: PFAS Litigation Will Ultimately Cap Upside Despite Turnaround Progress

3M to Showcase Industry-Advancing Solutions, New Ai-Powered Innovation Tool At Ces 2026

MMM: Turnaround Progress Will Face Ongoing PFAS Litigation And Portfolio Reshaping Risks

MMM: Shares Will Balance Turnaround Progress With Litigation and Asset Sale Uncertainty

Insider notifies of intention to sell stock

Third quarter dividend of US$0.73 announced

MMM: Shares Will Balance Turnaround Progress With Ongoing Litigation and Portfolio Changes

3M Company Declares Dividend for the Fourth Quarter of 2025, Payable Dec. 12, 2025

Insider notifies of intention to sell stock

Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

3M Company Revises Earnings Guidance for the Full Year 2025

Analysts Divided on 3M as Fair Value Rises Amid New Initiatives and Persistent Risks